HIV Infection of Macrophages: Implications for Pathogenesis and Cure
- PMID: 28752134
- PMCID: PMC5526341
- DOI: 10.20411/pai.v2i2.204
HIV Infection of Macrophages: Implications for Pathogenesis and Cure
Abstract
Although CD4+ T cells represent the major reservoir of persistent HIV and SIV infection, accumulating evidence suggests that macrophages also contribute. However, investigations of the role of macrophages are often underrepresented at HIV pathogenesis and cure meetings. This was the impetus for a scientific workshop dedicated to this area of study, held in Cambridge, MA in January 2017. The workshop brought together experts in the fields of HIV/SIV immunology and virology, macrophage biology and immunology, and animal models of HIV/SIV infection to discuss the role of macrophages as a physiologically relevant viral reservoir, and the implications of macrophage infection for HIV pathogenesis and strategies for cure. While still controversial, there is an emerging theory that infected macrophages likely persist in the setting of combination antiretroviral therapy. These macrophages could then drive persistent inflammation and contribute to the viral reservoir, which indicates the importance of addressing macrophages as well as CD4+ T cells with future therapeutic strategies.
Keywords: HIV/SIV pathogenesis; animal models of HIV infection; macrophages; replication competent virus; viral reservoir.
Conflict of interest statement
POTENTIAL CONFLICTS OF INTEREST The authors declare no conflicts of interest.
Figures
Similar articles
-
Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir.mBio. 2017 Aug 15;8(4):e01186-17. doi: 10.1128/mBio.01186-17. mBio. 2017. PMID: 28811349 Free PMC article.
-
Myeloid and CD4 T Cells Comprise the Latent Reservoir in Antiretroviral Therapy-Suppressed SIVmac251-Infected Macaques.mBio. 2019 Aug 20;10(4):e01659-19. doi: 10.1128/mBio.01659-19. mBio. 2019. PMID: 31431552 Free PMC article.
-
Infectious Virus Persists in CD4+ T Cells and Macrophages in Antiretroviral Therapy-Suppressed Simian Immunodeficiency Virus-Infected Macaques.J Virol. 2019 Jul 17;93(15):e00065-19. doi: 10.1128/JVI.00065-19. Print 2019 Aug 1. J Virol. 2019. PMID: 31118264 Free PMC article.
-
The HIV Reservoir in Monocytes and Macrophages.Front Immunol. 2019 Jun 26;10:1435. doi: 10.3389/fimmu.2019.01435. eCollection 2019. Front Immunol. 2019. PMID: 31297114 Free PMC article. Review.
-
HIV Persistence in Adipose Tissue Reservoirs.Curr HIV/AIDS Rep. 2018 Feb;15(1):60-71. doi: 10.1007/s11904-018-0378-z. Curr HIV/AIDS Rep. 2018. PMID: 29423731 Free PMC article. Review.
Cited by
-
Promoting Undetectable Equals Untransmittable in Sub-Saharan Africa: Implication for Clinical Practice and ART Adherence.Int J Environ Res Public Health. 2020 Aug 25;17(17):6163. doi: 10.3390/ijerph17176163. Int J Environ Res Public Health. 2020. PMID: 32854292 Free PMC article. Review.
-
Pathways towards human immunodeficiency virus elimination.EBioMedicine. 2020 Mar;53:102667. doi: 10.1016/j.ebiom.2020.102667. Epub 2020 Feb 27. EBioMedicine. 2020. PMID: 32114397 Free PMC article. Review.
-
The Effect of JAK1/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency.Front Immunol. 2021 Aug 31;12:720697. doi: 10.3389/fimmu.2021.720697. eCollection 2021. Front Immunol. 2021. PMID: 34531866 Free PMC article.
-
Macrophage Migration Inhibitory Factor (MIF) Promotes Increased Proportions of the Highly Permissive Th17-like Cell Profile during HIV Infection.Viruses. 2022 Oct 9;14(10):2218. doi: 10.3390/v14102218. Viruses. 2022. PMID: 36298774 Free PMC article.
-
HIV-1 is rarely detected in blood and colon myeloid cells during viral-suppressive antiretroviral therapy.AIDS. 2019 Jul 1;33(8):1293-1306. doi: 10.1097/QAD.0000000000002195. AIDS. 2019. PMID: 30870200 Free PMC article.
References
-
- Swirski FK, Robbins CS, Nahrendorf M. Development and Function of Arterial and Cardiac Macrophages. Trends Immunol. 2016;37(1):32–40. PubMed PMID: 26748179. Pubmed Central PMCID: PMC4706986. doi: 10.1016/j.it.2015.11.004 - DOI - PMC - PubMed
-
- Ensan S, Li A, Besla R, Degousee N, Cosme J, Roufaiel M, Shikatani EA, El-Maklizi M, Williams JW, Robins L, Li C, Lewis B, Yun TJ, Lee JS, Wieghofer P, Khattar R, Farrokhi K, Byrne J, Ouzounian M, Zavitz CC, Levy GA, Bauer CM, Libby P, Husain M, Swirski FK, Cheong C, Prinz M, Hilgendorf I, Randolph GJ, Epelman S, Gramolini AO, Cybulsky MI, Rubin BB, Robbins CS. Self-renewing resident arterial macrophages arise from embryonic CX3CR1(+) precursors and circulating monocytes immediately after birth. Nat Immunol. 2016;17(2):159–68. PubMed PMID: 26642357. doi: 10.1038/ni.3343 - DOI - PubMed
-
- Kuritzkes DR. Why cure, why now? J Med Ethics. 2017;43(2):67–70. PubMed PMID: 27273887. Pubmed Central PMCID: PMC5293855. doi: 10.1136/medethics-2015-103113 - DOI - PMC - PubMed
-
- Delagreverie HM, Delaugerre C, Lewin SR, Deeks SG, Li JZ. Ongoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory Agents. Open Forum Infect Dis. 2016;3(4):ofw189 PubMed PMID: 27757411. Pubmed Central PMCID: PMC5066458. doi: 10.1093/ofid/ofw189 - DOI - PMC - PubMed
-
- Bar KJ, Sneller MC, Harrison LJ, Justement JS, Overton ET, Petrone ME, Salantes DB, Seamon CA, Scheinfeld B, Kwan RW, Learn GH, Proschan MA, Kreider EF, Blazkova J, Bardsley M, Refsland EW, Messer M, Clarridge KE, Tustin NB, Madden PJ, Oden K, O'Dell SJ, Jarocki B, Shiakolas AR, Tressler RL, Doria-Rose NA, Bailer RT, Ledgerwood JE, Capparelli EV, Lynch RM, Graham BS, Moir S, Koup RA, Mascola JR, Hoxie JA, Fauci AS, Tebas P, Chun TW. Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption. N Engl J Med. 2016;375(21):2037–50. PubMed PMID: 27959728. doi: 10.1056/NEJMoa1608243 - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials